Patents Assigned to Okava Pharmaceuticals, Inc.
  • Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
    Patent number: 11786505
    Abstract: The present disclosure provides methods and compositions for modified delivery of mycophenolic acid active agents, including mycophenolate sodium, in canine subjects. Presently disclosed methods and compositions are useful, for example, to treat autoimmune diseases, blood disorders, and immune rejection related to transplant or graft procedures.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: October 17, 2023
    Assignee: Okava Pharmaceuticals, Inc.
    Inventors: Michael Klotsman, Padmaja Shivanand, Wayne H. Anderson, Gayatri Sathyan
  • Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
    Patent number: 11633378
    Abstract: The present disclosure provides methods and compositions for modified delivery of mycophenolic acid active agents, including sodium mycophenolate, in veterinary subjects. Presently disclosed methods and compositions are useful, for example, to treat autoimmune diseases, blood disorders associated with IMPDH activity, and immune rejection related to transplant or graft procedures.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: April 25, 2023
    Assignee: Okava Pharmaceuticals, Inc.
    Inventors: Michael Klotsman, Padmaja Shivanand, Wayne H. Anderson, Gayatri Sathyan